Ubs Group Ag Immucell Corp Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Immucell Corp stock. As of the latest transaction made, Ubs Group Ag holds 12,580 shares of ICCC stock, worth $63,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,580

Previous 15,942 21.09%

Holding current value

$63,906

Previous $57,000 12.28%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$3.48 - $5.15 $11,699 - $17,314	-3,362 Reduced 21.09%	12,580 $64,000
Q3 2024 Nov 14, 2024	BUY	$3.53 - $4.46 $46,832 - $59,170	13,267 Added 495.96%	15,942 $57,000
Q2 2024 Aug 13, 2024	SELL	$4.18 - $5.48 $7,419 - $9,727	-1,775 Reduced 39.89%	2,675 $12,000
Q1 2024 May 13, 2024	BUY	$4.73 - $5.47 $13,953 - $16,136	2,950 Added 196.67%	4,450 $23,000
Q4 2023 Feb 09, 2024	SELL	$4.45 - $5.47 $427 - $525	-96 Reduced 6.02%	1,500 $7,000
Q3 2023 Nov 09, 2023	SELL	$4.53 - $5.61 $471 - $583	-104 Reduced 6.12%	1,596 $8,000
Q2 2023 Aug 11, 2023	SELL	$4.64 - $5.98 $445 - $574	-96 Reduced 5.35%	1,700 $8,000
Q1 2023 May 12, 2023	BUY	$4.85 - $7.84 $1,435 - $2,320	296 Added 19.73%	1,796 $9,000
Q3 2022 Nov 10, 2022	SELL	$7.04 - $9.1 $8,081 - $10,446	-1,148 Reduced 43.35%	1,500 $11,000
Q2 2022 Aug 10, 2022	BUY	$7.7 - $10.71 $5,251 - $7,304	682 Added 34.69%	2,648 $23,000
Q1 2022 May 16, 2022	SELL	$8.0 - $10.06 $3,056 - $3,842	-382 Reduced 16.27%	1,966 $19,000
Q3 2021 Nov 15, 2021	BUY	$8.54 - $10.24 $2,117 - $2,539	248 Added 11.81%	2,348 $22,000
Q1 2021 May 12, 2021	SELL	$5.98 - $11.88 $7,576 - $15,051	-1,267 Reduced 37.63%	2,100 $20,000
Q4 2020 Feb 11, 2021	BUY	$5.21 - $6.42 $5,475 - $6,747	1,051 Added 45.38%	3,367 $21,000
Q3 2020 Nov 12, 2020	BUY	$4.98 - $6.35 $1,075 - $1,371	216 Added 10.29%	2,316 $12,000
Q1 2020 May 01, 2020	SELL	$3.79 - $5.92 $11,081 - $17,310	-2,924 Reduced 58.2%	2,100 $8,000
Q4 2019 Feb 14, 2020	SELL	$4.81 - $5.57 $8,754 - $10,137	-1,820 Reduced 26.59%	5,024 $26,000
Q3 2019 Nov 14, 2019	BUY	$5.15 - $6.55 $7,894 - $10,041	1,533 Added 28.86%	6,844 $38,000
Q2 2019 Aug 14, 2019	BUY	$5.89 - $6.86 $7,721 - $8,993	1,311 Added 32.78%	5,311 $35,000
Q4 2018 Feb 14, 2019	SELL	$6.4 - $9.03 $1,600 - $2,257	-250 Reduced 5.88%	4,000 $28,000
Q3 2018 Nov 14, 2018	SELL	$6.5 - $8.99 $9,932 - $13,736	-1,528 Reduced 26.45%	4,250 $35,000
Q2 2018 Aug 14, 2018	BUY	$6.75 - $8.28 $4,833 - $5,928	716 Added 14.14%	5,778 $39,000
Q1 2018 May 15, 2018	BUY	$6.93 - $8.27 $7,359 - $8,782	1,062 Added 26.55%	5,062 $35,000
Q3 2017 Nov 14, 2017	SELL	$5.44 - $7.7 $8,671 - $12,273	-1,594 Reduced 28.49%	4,000 $26,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,143 Added 128.23%	5,594 $41,000
Q1 2017 Nov 14, 2017	BUY	N/A	2,451	2,451 $14,000

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.2M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $39.4M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account